Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. PTIX.NASDAQ

Protagenic Therapeutics (PTIX NASDAQ) stock market data APIs

$0.7008 -0(-0%) as of July 26, 2024
Price chart is built with Anychart

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.

Protagenic Therapeutics Financial Data Overview

0.7013
0.7008
-
0.7343
0.7007
0.6797-2.19
3 120 K
4 452 K
0
-0.3829
0.285
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'PTIX',
Type: 'Common Stock',
Name: 'Protagenic Therapeutics',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000HQJ4R5',
ISIN: NULL,
CUSIP: NULL,
CIK: '1022899',
EmployerIdNumber: '06-1390025',
FiscalYearEnd: 'December',
IPODate: '2016-01-05',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Protagenic Therapeutics Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -5 485 339
  • Earnings Per Share -1.37
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Protagenic Therapeutics Earnings via APIs

  • Latest Release 2024-05-15
  • EPS/Forecast NaN

Get Protagenic Therapeutics End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Protagenic Therapeutics latest news via APIs

Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update

NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, tod...
  • BIOPHARMACEUTICAL
  • DR. GARO ARMEN
  • INC
  • NASDAQ: PTIX
  • NASDAQ:PTIX
  • PRESS RELEASES
  • PROTAGENIC THERAPEUTICS
  • PSYCHIATRIC DISORDERS
  • THIRD QUARTER 2021 RESULTS

Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ET

Scientific rationale and evidence for PT00114 in the treatment of Depression, Anxiety, PTSD and Addiction to be discussed NEW YORK, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc....
  • ANXIETY
  • BIOPHARMACEUTICAL COMPANY
  • DEPRESSION
  • INC
  • NASDAQ: PTIX
  • PRESS RELEASES
  • PROTAGENIC THERAPEUTICS
  • PT00114
  • PTSD
  • TREATMENT
  • VIRTUAL SCIENCE
Do you have any questions?
support@eodhistoricaldata.com